In this recorded webinar hosted by Oxford Nanopore Technologies, scientists from Ascend Advanced Therapies discuss how they have implemented Oxford Nanopore sequencing to advance the characterisation of recombinant adeno-associated virus (rAAV) vectors.
Our approach enables high-resolution analysis of biological products, compared with legacy methods, including identity, truncation hotspots, product-related DNA impurities, and encapsidated host-cell DNA, providing actionable insights without extending turnaround times or increasing sample requirements.
Ready to chat to a member of the team about bringing Oxford Nanopore sequencing into your analytical characterization?
"*" indicates required fields
